Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Amide antibacterial agents with potential in gastric disorders in development at Mitsubishi

Jan. 26, 1999

Chinese herbal medicines prove effective in some IBS patients

Jan. 21, 1999

Cantab studies validate novel approach to treating IBD

Jan. 20, 1999

Eradication of H. pylori has dubious therapeutic effect in patients with nonulcer dyspepsia

Jan. 18, 1999

PAF antagonist safe but not effective in the treatment of ulcerative colitis

Jan. 13, 1999

Novel antiviral phenylpropenamide derivative for HBV

Jan. 12, 1999

Preclinical studies demonstrate mechanism of action, efficacy of anti-HBV agent

Jan. 12, 1999

Chinese authorities approve anti-HBV drug for marketing

Jan. 11, 1999

Sigma ligands synthesized at Jouveinal, evaluated and claimed for GI disorders

Jan. 8, 1999

Oxis announces initial results of phase IIa clinical trial in ulcerative colitis

Jan. 8, 1999

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...